Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 0/6 |
Dividends | 0/6 |
RushNet, Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$0.0003 |
52 Week High | US$0.0009 |
52 Week Low | US$0.0001 |
Beta | 1.6 |
1 Month Change | -25.00% |
3 Month Change | 50.00% |
1 Year Change | -40.00% |
3 Year Change | -70.00% |
5 Year Change | -80.00% |
Change since IPO | -100.00% |
Recent News & Updates
Recent updates
Shareholder Returns
RSHN | US Healthcare | US Market | |
---|---|---|---|
7D | 0% | 2.0% | 1.2% |
1Y | -40.0% | 3.4% | 24.9% |
Return vs Industry: RSHN underperformed the US Healthcare industry which returned 3.6% over the past year.
Return vs Market: RSHN underperformed the US Market which returned 24.7% over the past year.
Price Volatility
RSHN volatility | |
---|---|
RSHN Average Weekly Movement | 56.8% |
Healthcare Industry Average Movement | 7.2% |
Market Average Movement | 6.0% |
10% most volatile stocks in US Market | 16.6% |
10% least volatile stocks in US Market | 3.0% |
Stable Share Price: RSHN's share price has been volatile over the past 3 months.
Volatility Over Time: RSHN's weekly volatility has decreased from 62% to 57% over the past year, but is still higher than 75% of US stocks.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
n/a | 18 | Michael Cunha | heliosdx.com |
RushNet, Inc. provides laboratory diagnostic testing services. It offers high-complexity urine drug testing, behavioral drug testing, allergy droplet cards, oral fluids, and infectious disease services. The company is based in Jacksonville, Florida.
RushNet, Inc. Fundamentals Summary
RSHN fundamental statistics | |
---|---|
Market cap | US$1.75m |
Earnings (TTM) | -US$664.65k |
Revenue (TTM) | US$6.90m |
0.4x
P/S Ratio-4.0x
P/E RatioIs RSHN overvalued?
See Fair Value and valuation analysisEarnings & Revenue
RSHN income statement (TTM) | |
---|---|
Revenue | US$6.90m |
Cost of Revenue | US$1.52m |
Gross Profit | US$5.37m |
Other Expenses | US$6.04m |
Earnings | -US$664.65k |
Last Reported Earnings
Dec 31, 2022
Next Earnings Date
n/a
Earnings per share (EPS) | -0.000076 |
Gross Margin | 77.90% |
Net Profit Margin | -9.63% |
Debt/Equity Ratio | 1,363.3% |
How did RSHN perform over the long term?
See historical performance and comparison